
    
      This randomized controlled trial will enroll 96 migraine patients without aura from the Third
      Affiliated Hospital of Zhejiang Chinese Medical University. All patients will be randomly
      assigned to either the acupuncture combined with placebo group or sham acupuncture combined
      with medication group through a randomization system. Primary outcome will be pain intensity
      assessed by visual analogue scale (VAS) scale. Secondary outcomes will include
      migraine-specific quality of life (MSQOL) scale and headache needs assessment survey (HANA)
      questionnaire scale.
    
  